CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication
Open accessThe DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index; 30 of the 114 sources its claims cite were checked for support.
Abstract
p21Waf/CIP1 is a small unstructured protein that binds and inactivates cyclin-dependent kinases (CDKs). To this end, p21 levels increase following the activation of the p53 tumor suppressor. CDK inhibition by p21 triggers cell-cycle arrest in the G1 and G2 phases of the cell cycle. In the absence of exogenous insults causing replication stress, only residual p21 levels are prevalent that are insufficient to inhibit CDKs. However, research from different laboratories has demonstrated that these residual p21 levels in the S phase control DNA replication speed and origin firing to preserve genomic stability. Such an S-phase function of p21 depends fully on its ability to displace partners from chromatin-bound proliferating cell nuclear antigen (PCNA). Vice versa, PCNA also regulates p21 by preventing its upregulation in the S phase, even in the context of robust p21 induction by γ irradiation. Such a tight regulation of p21 in the S phase unveils the potential that CDK-independent functions of p21 may have for the improvement of cancer treatments.
Overview
CoChat Summary
TL;DR
This review argues that p21 has CDK-independent, PCNA-dependent functions in S phase: residual p21 modulates DNA replication speed and origin firing, while p21 is actively degraded in S phase even after DNA damage. These S-phase functions may be relevant to cancer therapy, particularly through effects on translesion synthesis.
Key findings
- p21 is a 165-amino-acid protein; its C-terminal PCNA-binding region (aa139–164) contains a PIP degron with core QTSMTDFY (aa144–151). Flanking sequences contribute strongly: removing them drops PCNA affinity 10-fold, and replacing them with hydrophilic or negatively charged sequences reduces affinity by four orders of magnitude.
- In S phase, p21 remains at its lowest or undetectable levels and is not upregulated by γ irradiation, NCS, or nutlin-3; CRL4Cdt2 degrades PCNA-bound p21. Cellular p21/PCNA ratios reportedly never exceed 1:1, whereas blocking NER in vitro requires ≥10:1 and blocking replicative DNA synthesis in vitro requires 100:1, making direct inhibition of replicative polymerases by endogenous S-phase p21 unlikely.
- Residual S-phase p21 is a positive regulator of nascent DNA elongation: p21 downregulation impairs elongation and increases common fragile-site instability and micronuclei, via dysregulated pol κ loading onto PCNA. A separate report found p21 downregulation increased fork elongation, but both support that residual p21 controls replication speed.
- In p53-deficient models, p21 overexpression caused CDT1/CDC6/ORC upregulation, rereplication, asymmetric slow forks, and DSBs; p21–PCNA interaction prevented chromosome fusions and micronuclei. After UV, p21 downregulation permits TLS, whereas stable p21 blocks recruitment of pol η, κ, ι, and Rev1 and increases cell death and genomic instability.
Methods
- Narrative review; no primary experimental data. It synthesizes published literature on p21, PCNA, CDKs, DNA replication, DDR, TLS, and cancer therapy.
- Evidence discussed includes cell lines (e.g., MCF-7, SAOS-2, HCT116, Li-Fraumeni fibroblasts), C. elegans, live-cell imaging, single-cell analysis, in vitro binding/replication assays, and tumor marker colocalization; no systematic search or meta-analysis is described.
Limitations
- Stated: The review notes unresolved issues: whether cellular p21 levels suffice to displace replicative DNA polymerases from active replisomes; the mechanism by which S-phase p21–PCNA interaction triggers arrest outside S phase; inconclusive in vivo NER effects; and conflicting reports on whether p21 downregulation reduces or increases fork elongation, with different siRNAs and no p21-null models in one study.
- Evident: As a narrative review, it lacks a systematic search strategy, formal quality assessment, or quantitative synthesis; conclusions rely on selected literature and author interpretation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Cell cycle imposes strong regulation on p21 levels in S phase. Levels of fluorescence-tagged p21, PCNA, and CDK activities presented by black, purple, and orange lines, respectively. Endogenous p21 levels not shown, as live image experiments focused on fluorescence-tagged p21. Only in G1 and G2 did p21 levels rise to an extent that could inhibit cyclin–kinase complexes such as CycE/CDK2. Since p21 levels in G1 are very heterogeneous, multiple black lines represent such dispersion in p21 expression. Length of the G1 phase correlates with p21 levels, which were higher than p21 levels in Phase G2 [16]. Whether p21 controls PCNA functions in G1 is still debated, but p21 overexpression levels, which are similar to highest levels reached by endogenous p21 after DNA damage, are not sufficient to modulate replicative DNA synthesis or nucleotide excision repair in G1 [51]. In S phase, levels of fluorescence-tagged p21 were undetectable both in unperturbed conditions and after γ-irradiation, nutlin-3, or neocarzinostatin (NCS) treatment, which are all well-characterized inducers of p21 [16,67,68]. These results indicate that excess of exogenous p21 is strongly prevented in the S phase. Either Cdt2 downregulation or the disruption of the PIP box of p21 allowed p21 upregulation in the S phase, indicating CRL4Cdt2 that degrades PCNA-bound p21, tightly controlling p21 levels in the S phase [16,67]. p21 represented as black linear and unstructured peptide; dotted p21 represent p21 degradation.](https://figures.cochat.ai/paper-figures/008b4a1d79af4057afa866d8b35c1c67/cdk-independent-and-pcna-dependent-functions-of-p21-in-dna-replication-figure-2.jpg)
![Figure 3 Alterations of endogenous p21 levels in S phase cause genomic instability. Endogenous p21 S normal levels are within the segmented gray box, interacting with PCNA in replication factories [79]. Such p21 levels are required to maintain genomic stability. Both positive and negative changes in p2l levels are detrimental to cell genomic stability. (bottom) Downregulation of p21 levels in S causes alterations in nascent DNA elongation speed in a manner that depends on p21–PCNA interaction [79,82]. Mechanism underlying the promotion of nascent DNA elongation by p21 involves the prevention of dysregulated loading of specialized polymerases to sites of DNA synthesis, favoring the utilization of processive polymerases on undamaged templates. Under such experiment settings, p21 downregulation causes genomic instability in a manner that depends on loss of p21–PCNA interaction [79]. The deaccelerating role of p21, oppositely, also depends on p21–PCNA interaction [82]. (top) While p53-proficient cells do not allow p21 upregulation in the S phase, p53-deficient cells escaping from a senescent-like phenotype allow DNA replication in the context of p21 overexpression. Increased p21 levels in the S phase saturate the CRL4Cdt2 E3 ligase, causing an upregulation of other CRL4Cdt2 targets involved in origin firing [71]. Alterations in replication choreography are followed by rereplication events and double-strand-break (DSB) accumulation that are channeled into error-prone repair, further fueling cell genomic instability [71,75].](https://figures.cochat.ai/paper-figures/44849e5b06254694a4cb09f5db5979ed/cdk-independent-and-pcna-dependent-functions-of-p21-in-dna-replication-figure-3.jpg)
![Figure 4 p21 overexpression in S phase triggers cell death by preventing DNA replication across DNA lesions. A) Endogenous p21 is degraded at sites of DNA lesions. Elimination of p21 [50] and concomitant ubiquitination of PCNA [24,98] promote loading of specialized DNA polymerases at forks stalled at DNA lesions [50]. In this way, p21 prevents loading such polymerases in undamaged templates [79], but when DNA lesions are encountered by replication forks, rapid CRLCdt2-mediated removal of p21 facilitates replication across DNA lesions (dotted p21 represents p21 degradation) [50]. B) When p21 degradation is prevented in the context of high PCNA ubiquitination, the recruitment of specialized polymerases to replication factories is impaired. Replicative polymerases stall persistently at DNA lesions, and forks collapse, triggering cell death and genomic instability [50]. Stable p21–PCNA interaction is essential for such a role of p21 in TLS inhibition.](https://figures.cochat.ai/paper-figures/9f1e606217e24e00824a06fb71ab50ca/cdk-independent-and-pcna-dependent-functions-of-p21-in-dna-replication-figure-4.jpg)
Verification
Claims the paper makes
22 Valid · 1 Not valid · 51 Not checked · 24 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“After γ irradiation, the CRLCdt2-dependent degradation of p21 was triggered by ATM (ataxia telangiectasia mutatated) activation [66].”
§ CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication > 3. p21 Levels are Differentially Regulated during and by Cell Cycle
What the sources say
- Disputedcites [66] Stuart, 2009, Ionizing radiation induces ATM-independent degradation of p21Cip1 in transformed cells, J. Biol. Chem. sourceExperimental — accuracy not yet measured
The Discussion says that ionizing-radiation-induced p21 degradation requires DDB1–Cdt2 but is independent of ATM. The Results report that inhibiting ATM did not prevent degradation and that degradation occurred with nearly identical kinetics in cells with and without ATM. Thus the cited paper contradicts the claim that ATM activation triggers the process. (LLM, conf=0.95)
Checked by a reasoning model — may be wrong.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“While the p21/PCNA ratio was reported to never exceed a 1:1 ratio in cells [37,38], a ratio of at least 10:1 is required to block DNA repair by nucleotide excision repair (NER) in vitro [38,39,40,41].”
§ CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication > 2. Can Cell-Cycle Arrest Be Achieved by p21–PCNA Interaction?
What the sources say
- Not checked yetcites [38] Luo, 1995, Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1, Nature source
- Not checked yetcites [39] Pan, 1995, Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21, J. Biol. Chem. source
- Not checked yetcites [40] Shivji, 1998, Resistance of human nucleotide excision repair synthesis in vitro to p21Cdn1, Oncogene source
- Partly supportedcites [41] Cooper, 1999, The C-terminal domain of p21 inhibits nucleotide excision repair In vitro and In vivo, Mol. Biol. Cell sourceExperimental — accuracy not yet measured
The Discussion reports that this study needed a p21:PCNA ratio of 50:1 for 50% inhibition of in vitro NER, so its own result exceeds 10:1. But it also reports that Pan et al. observed 50% inhibition at 3:1; the paper therefore does not establish 10:1 as a general minimum. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“After the initial loss of proliferation capacity, a fraction of p21-overexpressing cells evaded arrest/senescence, displaying upregulation of CDT1, CDC6, and ORC, which are all regulators of replication origin licensing [74].”
§ CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication > 4. p21 Exerts Specific Functions at S-Phase-Specific Level, Regulating Genomic Stability through PCNA Interaction
What the sources say
- Supportedcites [74] Duzdevich, 2015, The dynamics of eukaryotic replication initiation: Origin specificity, licensing, and firing at the single-molecule level, Mol. Cell source
The citation follows the clause identifying CDT1, CDC6, and ORC as regulators of replication origin licensing, not the preceding observation about p21-overexpressing cells. The Results section, “Mcm2-7 Loading Occurs Preferentially at ARS1” (page unavailable), describes Mcm2-7/Cdt1 in loading reactions and states that loading depends on ORC and Cdc6; the Discussion explicitly addresses Mcm2-7/Cdt1 recruitment and origin licensing. (LLM, conf=0.90)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The dependency on PCNA was confirmed using a p21 mutant with a disrupted PIP box (Q144A, M147A, and F150A), which did not cause CDT1 and CDC6 upregulation [71].”
§ CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication > 4. p21 Exerts Specific Functions at S-Phase-Specific Level, Regulating Genomic Stability through PCNA Interaction
What the sources say
- Partly supportedcites [71] Galanos, 2016, Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing, Nat. Cell Biol. sourceExperimental — accuracy not yet measured
The Results subsection 'p53-independent stimulation of p21WAF1/Cip1 up-regulates key replication licensing factors' states that a mutant p21WAF1/Cip1 with three substitutions in its PIP degron motif, abrogating PCNA interaction (required for CRL4CDT2 targeting), 'did not augment Cdt1 expression', favouring the saturation/competition mechanism (Fig. 2b); the Material and Methods ('siRNA transfections and retrovirus infections') identify the mutant p21PCNA as carrying Q144, M147, F150 → A substitutions, so the PIP-box residue detail and the CDT1 part are supported. However, our copy never reports that this PCNA-binding-defective mutant failed to up-regulate CDC6 — Cdc6 is discussed as stabilized in p21WAF1/Cip1-expressing cells via reduced Cdh1/Fzr1 and Cdk2-mediated Ser54 phosphorylation (Supplemental Fig. S5c), and the only mutant result cited there is reduced re-replication/DNA damage (Supplemental Fig. S5,S9). The CDC6 element of the claim is therefore not attributed to this source. (LLM, conf=0.78)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Because both rereplication and error-prone DSB repair fuel genomic instability, these observations indicate a pro-oncogenic role of p21, at least in p53-negative cancer [71,75].”
§ CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication > 4. p21 Exerts Specific Functions at S-Phase-Specific Level, Regulating Genomic Stability through PCNA Interaction
What the sources say
- Supportedcites [71] Galanos, 2016, Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing, Nat. Cell Biol. source
The Discussion (page not available in our copy) explicitly describes p21 as capable of oncogenic activity and identifies p53 inactivation as the factor that shifts it toward that role. It also links p21-associated rereplication and lower-fidelity repair to genomic instability, supporting the citing sentence’s rationale. (LLM, conf=0.94)
- Supportedcites [75] Galanos, 2018, Mutational signatures reveal the role of RAD52 in p53-independent p21-driven genomic instability, Genome Biol. source
The Conclusions state that chronic p53-independent p21 expression causes genome re-replication and error-prone repair of double-strand breaks, thereby fueling genomic instability and promoting cancer development. This supports the claimed pro-oncogenic role in the stated p53-negative context. (LLM, conf=0.93)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
69 more claims · 15 with their cited sources checked
Create a free account to see all 98 claims and to verify the 84 references still open.
- It may state two separate claims as one. 17
- Probably not a substantial claim. 9
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“p21 strongly binds this DNA replication factor via a canonical PCNA-interacting protein box motif (53).”
From A genome-wide screen reveals that Dyrk1A kinase promotes nucleotide excision repair by preventing aberrant overexpression of cyclin D1 and p21 (2023) · cites this paper as [53]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The origin of SASP factors can be traced using histological methods; however, secreted factors are normally small proteins poorly retained within cells, which makes their detection using IHC/IHF highly challenging, although there has been some success, for example, with IHC against IL-1α29 and IL-1β30.”
From Guidelines for minimal information on cellular senescence experimentation in vivo (2024) · cites this paper as [29]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication > 3. p21 Levels are Differentially Regulated during and by Cell Cycle
“After γ irradiation, the CRLCdt2-dependent degradation of p21 was triggered by ATM (ataxia telangiectasia mutatated) activation [66].”
§ CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication > References
“66. Stuart S.A. Wang J.Y. Ionizing radiation induces ATM-independent degradation of p21Cip1 in transformed cells”
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803 · cited 2×
“All defects observed when p21 is downregulated were phenocopied in HCT116 cells in which p21 was stably knocked out [14,79].”
Backgroundp21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712 · cited 2×
“Since SCFSkp2 degrades cyclin–CDK-bound p21 [1], it is possible that the main signal forcing p21 degradation in the S phase is associated with an E3 ligase that is active beyond the G1/S boundary.”
BackgroundMice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/369574a0 · Cited by 1,655
New functional activities for the p21 family of CDK inhibitors.
LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., & Harlow, E. (1997) · Genes & Development · doi:10.1101/gad.11.7.847 · Cited by 1,402
Radiation-induced cell cycle arrest compromised by p21 deficiency
Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., & Hannon, G. J. (1995) · Nature · doi:10.1038/377552a0 · Cited by 1,242 · cited 1×
“High p21 levels trigger arrest in Phases G1 and G2 of the cell cycle [5,14,15].”
BackgroundCDK inhibitors: Cell cycle regulators and beyond
Besson, A., Dowdy, S. F., & Roberts, J. M. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.013 · Cited by 1,152
Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage.
Karimian, A., Ahmadi, Y., & Yousefi, B. (2016) · DNA Repair · doi:10.1016/j.dnarep.2016.04.008 · Cited by 1,110
Inhibition of cyclin-dependent kinases by p21.
Harper, J. W., Elledge, S. J., Keyomarsi, K., Dynlacht, B., Tsai, L. H., Zhang, P., Dobrowolski, S., Bai, C., Connell-Crowley, L., & Swindell, E. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.4.387 · Cited by 1,023
Crystal structure of the eukaryotic DNA polymerase processivity factor PCNA
Krishna, T. S. R., Kong, X.-P., Gary, S., Burgers, P. M., & Kuriyan, J. (1994) · Cell · doi:10.1016/0092-8674(94)90014-0 · Cited by 902
Autoantibody to a nuclear antigen in proliferating cells
Miyachi, K., Fritzler, M. J., & Tan, E. M. (1978) · The Journal of Immunology · doi:10.4049/jimmunol.121.6.2228 · Cited by 874
Structure of the C-Terminal Region of p21WAF1/CIP1 Complexed with Human PCNA
Gulbis, J. M., Kelman, Z., Hurwitz, J., O'Donnell, M., & Kuriyan, J. (1996) · Cell · doi:10.1016/s0092-8674(00)81347-1 · Cited by 804
Spencer, S. L., Cappell, S. D., Tsai, F.-C., Overton, K. W., Wang, C. L., & Meyer, T. (2013) · Cell · doi:10.1016/j.cell.2013.08.062 · Cited by 698
Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair
Li, R., Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/371534a0 · Cited by 643
Prives, C. (1998) · Cell · doi:10.1016/s0092-8674(00)81774-2 · Cited by 623
Eukaryotic Translesion Polymerases and Their Roles and Regulation in DNA Damage Tolerance
Waters, L. S., Minesinger, B. K., Wiltrout, M. E., D'Souza, S., Woodruff, R. V., & Walker, G. C. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00034-08 · Cited by 591
Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1
Luo, Y., Hurwitz, J., & Massagué, J. (1995) · Nature · doi:10.1038/375159a0 · Cited by 549 · cited 2×
“While the p21/PCNA ratio was reported to never exceed a 1:1 ratio in cells [37,38], a ratio f at least 10:1 is required to block DNA repair by nucleotide ex ision repair (NER) in vi ro [38– 1].”
BackgroundSeparate domains of p21 involved in the inhibition of Cdk kinase and PCNA
Chen, J., Jackson, P. K., Kirschner, M. W., & Dutta, A. (1995) · Nature · doi:10.1038/374386a0 · Cited by 548
MDM2 inhibitors for cancer therapy
Vassilev, L. T. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.11.002 · Cited by 532 · cited 1×
“While the mechanisms of p53 induction by nutlin-3 and γ irradiation are dissimilar (nutlin-3 disrupts p53/MDM2 interaction [69], while γ irradiation attenuates such interaction via the phosphorylation of MDM-2 and p53 [70]), both treatments converge into the accumulation of a transcriptionally active p53 that can prom…”
BackgroundHigh speed of fork progression induces DNA replication stress and genomic instability
Maya-Mendoza, A., Moudry, P., Merchut-Maya, J. M., Lee, M., Strauss, R., & Bartek, J. (2018) · Nature · doi:10.1038/s41586-018-0261-5 · Cited by 514 · cited 6×
“Both reports [79,83] used the same cell line, but different siRNAs.”
BackgroundInfluentialMechanisms of accurate translesion synthesis by human DNA polymerase η
Masutani, C., Kusumoto, R., Iwai, S., & Hanaoka, F. (2000) · The EMBO Journal · doi:10.1093/emboj/19.12.3100 · Cited by 504
Role of the SCFSkp2 Ubiquitin Ligase in the Degradation of p21Cip1 in S Phase
Bornstein, G., Bloom, J., Sitry-Shevah, D., Nakayama, K., Pagano, M., & Hershko, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301774200 · Cited by 494
Roninson, I. B. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00847-3 · Cited by 443
Smith, M. L., Ford, J. M., Hollander, M. C., Bortnick, R. A., Amundson, S. A., Seo, Y. R., Deng, C., Hanawalt, P. C., & Fornace, A. J. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.10.3705-3714.2000 · Cited by 432
Flores-Rozas, H., Kelman, Z., Dean, F. B., Pan, Z. Q., Harper, J. W., Elledge, S. J., O'Donnell, M., & Hurwitz, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8655 · Cited by 416
Barr, A. R., Cooper, S., Heldt, F. S., Butera, F., Stoy, H., Mansfeld, J., Novák, B., & Bakal, C. (2017) · Nature Communications · doi:10.1038/ncomms14728 · Cited by 403 · cited 9×
“The levels of p21-GFP in Phase G2 are lower and less variable than in Phase G1, and they correlate to a lesser extent with G2 phase length [16].”
BackgroundResultInfluentialTranslesion synthesis: Y-family polymerases and the polymerase switch
LEHMANN, A., NIIMI, A., OGI, T., BROWN, S., SABBIONEDA, S., WING, J., KANNOUCHE, P., & GREEN, C. (2007) · DNA Repair · doi:10.1016/j.dnarep.2007.02.003 · Cited by 389 · cited 5×
“Because TLS events may protect tumor cells by favoring DNA replication, TLS is considered a potential target in cancer therapy [98,108,109].”
BackgroundInfluentialAbbas, T., Sivaprasad, U., Terai, K., Amador, V., Pagano, M., & Dutta, A. (2008) · Genes & Development · doi:10.1101/gad.1676108 · Cited by 366
Koumenis, C., Alarcon, R., Hammond, E., Sutphin, P., Hoffman, W., Murphy, M., Derr, J., Taya, Y., Lowe, S. W., Kastan, M., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1297-1310.2001 · Cited by 346
Xu, X., Xie, K., Zhang, X.-Q., Pridgen, E. M., Park, G. Y., Cui, D. S., Shi, J., Wu, J., Kantoff, P. W., Lippard, S. J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303958110 · Cited by 340
p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells
Cayrol, C., Knibiehler, M., & Ducommun, B. (1998) · Oncogene · doi:10.1038/sj.onc.1201543 · Cited by 337
Forging Ahead through Darkness: PCNA, Still the Principal Conductor at the Replication Fork
Choe, K. N., & Moldovan, G.-L. (2017) · Molecular Cell · doi:10.1016/j.molcel.2016.12.020 · Cited by 325
Proteasome-Mediated Degradation of p21 via N-Terminal Ubiquitinylation
Bloom, J., Amador, V., Bartolini, F., DeMartino, G., & Pagano, M. (2003) · Cell · doi:10.1016/s0092-8674(03)00755-4 · Cited by 322
Galanos, P., Vougas, K., Walter, D., Polyzos, A., Maya-Mendoza, A., Haagensen, E. J., Kokkalis, A., Roumelioti, F.-M., Gagos, S., Tzetis, M., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3378 · Cited by 308 · cited 9×
“By exploring markers of active replication (KI67) and p21 levels in human tumors, unexpected colocalization of p21 and ki67 was observed in approximately 5% to 7% of cells within p53-deficient tumors [71].”
BackgroundInfluentialThe Many Roles of PCNA in Eukaryotic DNA Replication
(2016) · The Enzymes · doi:10.1016/bs.enz.2016.03.003 · Cited by 294
PCNA on the crossroad of cancer
Stoimenov, I., & Helleday, T. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370605 · Cited by 289
DNA Polymerases that Propagate the Eukaryotic DNA Replication Fork
Garg, P., & Burgers, P. M. J. (2005) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230590935433 · Cited by 283
UV Irradiation Triggers Ubiquitin-Dependent Degradation of p21WAF1 to Promote DNA Repair
Bendjennat, M., Boulaire, J., Jascur, T., Brickner, H., Barbier, V., Sarasin, A., Fotedar, A., & Fotedar, R. (2003) · Cell · doi:10.1016/j.cell.2003.08.001 · Cited by 248 · cited 2×
“All these agents cause replication-fork stalling followed by ATR activation, a situation that may enhance further signaling events involved in p21 degradation [59,93].”
BackgroundGalea, C. A., Wang, Y., Sivakolundu, S. G., & Kriwacki, R. W. (2008) · Biochemistry · doi:10.1021/bi8006803 · Cited by 245
Nishitani, H., Shiomi, Y., Iida, H., Michishita, M., Takami, T., & Tsurimoto, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806045200 · Cited by 240
The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing
Kim, Y., Starostina, N. G., & Kipreos, E. T. (2008) · Genes & Development · doi:10.1101/gad.1703708 · Cited by 240
Al Bitar, S., & Gali-Muhtasib, H. (2019) · Cancers · doi:10.3390/cancers11101475 · Cited by 224
Bruning, J. B., & Shamoo, Y. (2004) · Structure · doi:10.1016/j.str.2004.09.018 · Cited by 206
A Small Molecule Targeting Mutagenic Translesion Synthesis Improves Chemotherapy
Wojtaszek, J. L., Chatterjee, N., Najeeb, J., Ramos, A., Lee, M., Bian, K., Xue, J. Y., Fenton, B. A., Park, H., Li, D., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.028 · Cited by 194
WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases
Ogryzko, V. V., Wong, P., & Howard, B. H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4877 · Cited by 193
Srivastava, A. K., Han, C., Zhao, R., Cui, T., Dai, Y., Mao, C., Zhao, W., Zhang, X., Yu, J., & Wang, Q.-E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421365112 · Cited by 188
Havens, C. G., & Walter, J. C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.05.012 · Cited by 179
Protein and its function based on a subcellular localization
Ćmielová, J., & Řezáčová, M. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23296 · Cited by 164
Deng, T., Yan, G., Song, X., Xie, L., Zhou, Y., Li, J., Hu, X., Li, Z., Hu, J., Zhang, Y., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714938115 · Cited by 162
Medema, R. H., Klompmaker, R., Smits, V. A., & Rijksen, G. (1998) · Oncogene · doi:10.1038/sj.onc.1201558 · Cited by 161
Regulation of Translesion Synthesis DNA Polymerase η by Monoubiquitination
Bienko, M., Green, C. M., Sabbioneda, S., Crosetto, N., Matic, I., Hibbert, R. G., Begovic, T., Niimi, A., Mann, M., Lehmann, A. R., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2009.12.039 · Cited by 161
Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21
Pan, Z.-Q., Reardon, J. T., Li, L., Flores-Rozas, H., Legerski, R., Sancar, A., & Hurwitz, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.22008 · Cited by 151
Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors
Starostina, N. G., & Kipreos, E. T. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.10.004 · Cited by 147 · cited 1×
“For details on such degradation mechanisms, please refer to [51,60].”
Backgroundp53 accumulates but is functionally impaired when DNA synthesis is blocked
Gottifredi, V., Shieh, S.-Y., Taya, Y., & Prives, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1036 · Cited by 147 · cited 1×
“γ-irradiation cannot trigger p21 accumulation in cells arrested in the S phase using ribonucleotide reductase inhibition by hydroxyurea [73].”
MethodSelf-citationReplication of damaged DNA by translesion synthesis in human cells
Lehmann, A. R. (2005) · FEBS Letters · doi:10.1016/j.febslet.2004.11.029 · Cited by 143
p53 and p21 Regulate Error-Prone DNA Repair to Yield a Lower Mutation Load
Avkin, S., Sevilya, Z., Toube, L., Geacintov, N. E., Chaney, S. G., Oren, M., & Livneh, Z. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.022 · Cited by 141
Punchihewa, C., Inoue, A., Hishiki, A., Fujikawa, Y., Connelly, M., Evison, B., Shao, Y., Heath, R., Kuraoka, I., Rodrigues, P., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.353201 · Cited by 135
Podust, V. N., Podust, L. M., Goubin, F., Ducommun, B., & Huebscher, U. (1995) · Biochemistry · doi:10.1021/bi00027a039 · Cited by 124 · cited 1×
“Intriguingly, the expression of a p21 mutant with a disrupted PCNA-binding domain (Q144A, M147A, and F150A [71]) caused arrest in G1 after γ-irradiation [67], suggesting that p21–PCNA interaction prevented rather than promoted cell-cycle arrest, as originally postulated based on its ability to displace replicative DNA…”
BackgroundDistinct mechanisms act in concert to mediate cell cycle arrest
Toettcher, J. E., Loewer, A., Ostheimer, G. J., Yaffe, M. B., Tidor, B., & Lahav, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806196106 · Cited by 112 · cited 1×
“p21 is also essential for the prevention of endoreduplication and induction of senescence after extended cell-cycle arrest [18,19].”
BackgroundThe PCNA interaction motifs revisited: thinking outside the PIP-box
Prestel, A., Wichmann, N., Martins, J. M., Marabini, R., Kassem, N., Broendum, S. S., Otterlei, M., Nielsen, O., Willemoës, M., Ploug, M., et al. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03150-0 · Cited by 112
Analysis of Wild-Type and Mutant p21 WAF-1 Gene Activities
Lin, J., Reichner, C., Wu, X., & J. Levine, A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1786 · Cited by 111
Dynamics of CDKN1A in Single Cells Defined by an Endogenous Fluorescent Tagging Toolkit
Stewart-Ornstein, J., & Lahav, G. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.045 · Cited by 110
P21Cip1/WAF1 downregulation is required for efficient PCNA ubiquitination after UV irradiation
Soria, G., Podhajcer, O. L., Prives, C. L., & Gottifredi, V. (2005) · Oncogene · doi:10.1038/sj.onc.1209315 · Cited by 109
Self-citationProliferating Cell Nuclear Antigen Structure and Interactions
Biasio, A. D., & Blanco, F. J. (2013) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-411637-5.00001-9 · Cited by 100
Laptenko, O., Beckerman, R., Freulich, E., & Prives, C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105680108 · Cited by 99
A Novel PCNA-Binding Motif Identified by the Panning of a Random Peptide Display Library
Xu, H., Zhang, P., Liu, L., & Lee, M. Y. W. T. (2001) · Biochemistry · doi:10.1021/bi010103+ · Cited by 95
Soria, G., Speroni, J., Podhajcer, O. L., Prives, C., & Gottifredi, V. (2008) · Journal of Cell Science · doi:10.1242/jcs.027730 · Cited by 94
Self-citationNakanishi, M., Robetorye, R. S., Pereira-Smith, O. M., & Smith, J. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.29.17060 · Cited by 92
Inhibition of mutagenic translesion synthesis: A possible strategy for improving chemotherapy?
Yamanaka, K., Chatterjee, N., Hemann, M. T., & Walker, G. C. (2017) · PLOS Genetics · doi:10.1371/journal.pgen.1006842 · Cited by 87
Lee, J. Y., Yu, S. J., Park, Y. G., Kim, J., & Sohn, J. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01461-06 · Cited by 85
Duzdevich, D., Warner, M. D., Ticau, S., Ivica, N. A., Bell, S. P., & Greene, E. C. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.03.017 · Cited by 81 · cited 1×
“After the initial loss of proliferation capacity, a fraction of p21-overexpressing cells evaded arrest/senescence, displaying upregulation of CDT1, CDC6, and ORC, which are all regulators of replication origin licensing [74].”
BackgroundThe C-terminal domain of p21 inhibits nucleotide excision repair In vitro and In vivo
Cooper, M. P., Balajee, A. S., & Bohr, V. A. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.7.2119 · Cited by 80 · cited 1×
“Some reports indicate a null effect of p21 on NER [54–58], while others reported that p21 overexpression causes NER inhibition [41,59].”
BackgroundPCNA-coupled p21 degradation after DNA damage: The exception that confirms the rule?
Soria, G., & Gottifredi, V. (2010) · DNA Repair · doi:10.1016/j.dnarep.2009.12.003 · Cited by 79
Self-citationThe p21 and PCNA partnership: A new twist for an old plot
Prives, C., & Gottifredi, V. (2008) · Cell Cycle · doi:10.4161/cc.7.24.7243 · Cited by 78
Self-citationOku, T., Ikeda, S., Sasaki, H., Fukuda, K., Morioka, H., Ohtsuka, E., Yoshikawa, H., & Tsurimoto, T. (1998) · Genes to Cells · doi:10.1046/j.1365-2443.1998.00199.x · Cited by 77 · cited 1×
“Experiments performed in vitro demonstrated that, indeed, p21 is potentially capable of preventing PCNA interaction with replication factors, including DNA polymerase δ, which is in charge of the elongation of the lagging strand [31].”
BackgroundBenamar, M., Guessous, F., Du, K., Corbett, P., Obeid, J., Gioeli, D., Slingluff, C. L., & Abbas, T. (2016) · eBioMedicine · doi:10.1016/j.ebiom.2016.06.023 · Cited by 77
Decreased p21 levels are required for efficient restart of DNA synthesis after S phase block
Gottifredi, V., McKinney, K., Poyurovsky, M. V., & Prives, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310373200 · Cited by 76
Self-citationOriganti, S., Cai, S.-R., Munir, A. Z., White, L. S., & Piwnica-Worms, H. (2013) · Oncogene · doi:10.1038/onc.2012.84 · Cited by 74
Dysregulation of DNA polymerase κ recruitment to replication forks results in genomic instability
Jones, M. V., Colnaghi, L., & Huang, T. T. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.457 · Cited by 72
Resistance of human nucleotide excision repair synthesis in vitro to p21Cdn1
Shivji, M. K., Ferrari, E., Ball, K., Hübscher, U., & Wood, R. D. (1998) · Oncogene · doi:10.1038/sj.onc.1202352 · Cited by 72
Adimoolam, S., Lin, C. X., & Ford, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102240200 · Cited by 71
Accuracy of lesion bypass by yeast and human DNA polymerase η
Washington, M. T., Johnson, R. E., Prakash, L., & Prakash, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121007298 · Cited by 71
A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpoint
Beckerman, R., Donner, A. J., Mattia, M., Peart, M. J., Manley, J. L., Espinosa, J. M., & Prives, C. (2009) · Genes & Development · doi:10.1101/gad.1795709 · Cited by 69
The S phase checkpoint: When the crowd meets at the fork
GOTTIFREDI, V, & PRIVES, C. (2005) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2005.02.011 · Cited by 68
Self-citationCazzalini, O., Perucca, P., Riva, F., Stivala, L. A., Bianchi, L. C., Vannini, V., Ducommun, B., & Prosperi, E. (2003) · Cell Cycle · doi:10.4161/cc.2.6.502 · Cited by 67
Mutational signatures reveal the role of RAD52 in p53-independent p21-driven genomic instability
Galanos, P., Pappas, G., Polyzos, A., Kotsinas, A., Svolaki, I., Giakoumakis, N. N., Glytsou, C., Pateras, I. S., Swain, U., Souliotis, V. L., et al. (2018) · Genome Biology · doi:10.1186/s13059-018-1401-9 · Cited by 67
Naryzhny, S., & Lee, H. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.09.022 · Cited by 66
Replication stress and genome rearrangements: lessons from yeast models
Lambert, S., & Carr, A. M. (2012) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2012.11.009 · Cited by 64
Activity and nature of p21 WAF1 complexes during the cell cycle
Cai, K., & Dynlacht, B. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12254 · Cited by 63
p21: structure and functions associated with cyclin-CDK binding
Ball, K. L. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5371-7_10 · Cited by 62
Targeting the Translesion Synthesis Pathway for the Development of Anti-Cancer Chemotherapeutics
Korzhnev, D. M., & Hadden, M. K. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00596 · Cited by 58
HENDEL, A., ZIV, O., GUERANGER, Q., GEACINTOV, N., & LIVNEH, Z. (2008) · DNA Repair · doi:10.1016/j.dnarep.2008.06.008 · Cited by 57
p21 promotes error-free replication-coupled DNA double-strand break repair
Mauro, M., Rego, M. A., Boisvert, R. A., Esashi, F., Cavallo, F., Jasin, M., & Howlett, N. G. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks612 · Cited by 56 · cited 2×
“In this regard, it should be mentioned that, in a manner that depends on CDK inactivation, p21 was reported to regulate the homologous recombination-mediated repair of double-strand-breaks (DSBs), a DNA lesion that is induced by γ irradiation [72].”
Backgroundp53-Dependent p21 mRNA Elongation Is Impaired when DNA Replication Is Stalled
Mattia, M., Gottifredi, V., McKinney, K., & Prives, C. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01520-06 · Cited by 55
Self-citationLerner, L. K., Francisco, G., Soltys, D. T., Rocha, C. R. R., Quinet, A., Vessoni, A. T., Castro, L. P., David, T. I. P., Bustos, S. O., Strauss, B. E., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1196 · Cited by 53
Self-citationUV Induces p21 Rapid Turnover Independently of Ubiquitin and Skp2
Lee, H., Zeng, S. X., & Lu, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605366200 · Cited by 53
Perucca, P., Cazzalini, O., Mortusewicz, O., Necchi, D., Savio, M., Nardo, T., Stivala, L. A., Leonhardt, H., Cardoso, M. C., & Prosperi, E. (2006) · Journal of Cell Science · doi:10.1242/jcs.02868 · Cited by 53
Sail, V., Rizzo, A. A., Chatterjee, N., Dash, R. C., Ozen, Z., Walker, G. C., Korzhnev, D. M., & Hadden, M. K. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.6b01144 · Cited by 52
Sequential replication-coupled destruction at G1/S ensures genome stability
Coleman, K. E., Grant, G. D., Haggerty, R. A., Brantley, K., Shibata, E., Workman, B. D., Dutta, A., Varma, D., Purvis, J. E., & Cook, J. G. (2015) · Genes & Development · doi:10.1101/gad.263731.115 · Cited by 51 · cited 1×
“Moreover, p21 degradation follows a strict timing, and the acceleration of p21 degradation causes stalled replication forks in mid-S phase and sensitivity to replication arrest [65].”
BackgroundUV-triggered p21 degradation facilitates damaged-DNA replication and preserves genomic stability
Mansilla, S. F., Soria, G., Vallerga, M. B., Habif, M., Martinez-Lopez, W., Prives, C., & Gottifredi, V. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt475 · Cited by 50 · cited 9×
“The impairment of TLS also affected nascent DNA elongation events, as revealed by the observation of single DNA molecules in DNA spreading assays [50].”
BackgroundInfluentialSelf-citationControl of DNA Damage Bypass by Ubiquitylation of PCNA
Ripley, B. M., Gildenberg, M. S., & Washington, M. T. (2020) · Genes · doi:10.3390/genes11020138 · Cited by 48
Tsanov, N., Kermi, C., Coulombe, P., Van der Laan, S., Hodroj, D., & Maiorano, D. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1400 · Cited by 47
Direct Interaction of Proliferating Cell Nuclear Antigen with the Small Subunit of DNA Polymerase δ
Lu, X., Tan, C.-K., Zhou, J.-Q., You, M., Carastro, L. M., Downey, K. M., & So, A. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200065200 · Cited by 47
Sheng, C., Mendler, I.-H., Rieke, S., Snyder, P., Jentsch, M., Friedrich, D., Drossel, B., & Loewer, A. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.031 · Cited by 45 · cited 8×
“Intriguingly, the expression of a p21 mutant with a disrupted PCNA-binding domain (Q144A, M147A, and F150A [71]) caused arrest in G1 after γ-irradiation [67], suggesting that p21–PCNA interaction prevented rather than promoted cell-cycle arrest, as originally postulated based on its ability to displace replicative DNA…”
BackgroundInfluentialMansilla, S. F., Bertolin, A. P., Bergoglio, V., Pillaire, M.-J., González Besteiro, M. A., Luzzani, C., Miriuka, S. G., Cazaux, C., Hoffmann, J.-S., & Gottifredi, V. (2016) · eLife · doi:10.7554/elife.18020 · Cited by 43
Self-citationMizushina, Y., Motoshima, H., Yamaguchi, Y., Takeuchi, T., Hirano, K., Sugawara, F., & Yoshida, H. (2009) · Marine Drugs · doi:10.3390/md7040624 · Cited by 42
Identification of the first small-molecule inhibitor of the REV7 DNA repair protein interaction
Actis, M. L., Ambaye, N. D., Evison, B. J., Shao, Y., Vanarotti, M., Inoue, A., McDonald, E. T., Kikuchi, S., Heath, R., Hara, K., et al. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.07.026 · Cited by 42
Kim, D. H., Budhavarapu, V. N., Herrera, C. R., Nam, H. W., Kim, Y. S., & Yew, P. R. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01135-09 · Cited by 36
A Comprehensive Strategy to Discover Inhibitors of the Translesion Synthesis DNA Polymerase κ
Yamanaka, K., Dorjsuren, D., Eoff, R. L., Egli, M., Maloney, D. J., Jadhav, A., Simeonov, A., & Lloyd, R. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045032 · Cited by 35
Combined CDKN1A/TP53 mutation in bladder cancer is a therapeutic target
Liu, Y., & Kwiatkowski, D. J. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0622-t · Cited by 35 · cited 2×
“Intriguingly, endogenous p21 expression in the S phase was recently reported to protect cancer cells from excessive DNA damage in the S phase, and cell killing by Wee1 (MK1775) and Chk1 (AZD6772) kinase inhibitors [84,85].”
BackgroundThe identification of translesion DNA synthesis regulators: Inhibitors in the spotlight
Bertolin, A. P., Mansilla, S. F., & Gottifredi, V. (2015) · DNA Repair · doi:10.1016/j.dnarep.2015.04.027 · Cited by 30 · cited 3×
“Such p21 is considered residual as it does not modulate unperturbed cell-cycle progression [77,78].”
BackgroundSelf-citationVillafañez, F., García, I. A., Carbajosa, S., Pansa, M. F., Mansilla, S., Llorens, M. C., Angiolini, V., Guantay, L., Jacobs, H., Madauss, K. P., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0724-7 · Cited by 30
Self-citationp21 limits S phase DNA damage caused by the Wee1 inhibitor MK1775
Hauge, S., Macurek, L., & Syljuåsen, R. G. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1593649 · Cited by 30
Ionizing radiation induces ATM-independent degradation of p21Cip1 in transformed cells
Stuart, S. A., & Wang, J. Y. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808810200 · Cited by 28
Wani, M. A., Wani, G., Yao, J., Zhu, Q., & Wani, A. A. (2002) · Carcinogenesis · doi:10.1093/carcin/23.3.403 · Cited by 27
Savio, M., Coppa, T., Cazzalini, O., Perucca, P., Necchi, D., Nardò, T., Stivala, L. A., & Prosperi, E. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.02.005 · Cited by 19
Watanabe, T., Marotta, M. L., Suzuki, R., Diede, S. J., Tapscott, S. J., Niida, A., Chen, X., Mouakkad, L., Kondratova, A. A., Giuliano, A. E., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.103 · Cited by 18
Vanarotti, M., Evison, B. J., Actis, M. L., Inoue, A., McDonald, E. T., Shao, Y., Heath, R. J., & Fujii, N. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.03.028 · Cited by 17
Federico, M. B., Siri, S. O., Calzetta, N. L., Paviolo, N. S., de la Vega, M. B., Martino, J., Campana, M. C., Wiesmüller, L., & Gottifredi, V. (2020) · Oncogene · doi:10.1038/s41388-020-1265-9 · Cited by 12
Self-citationHdm2- and proteasome-dependent turnover limits p21 accumulation during S phase
Ciznadija, D., Zhu, X.-H., & Koff, A. (2011) · Cell Cycle · doi:10.4161/cc.10.16.16725 · Cited by 11 · cited 4×
“SCFSkp2 did not contribute to such γ-irradiation-associated p21 proteolysis in the S phase [63].”
BackgroundInfluentialInhibition of DNA polymerase η by oxetanocin derivatives
Izuta, S. (2006) · Nucleic Acids Symposium Series · doi:10.1093/nass/nrl134 · Cited by 6
Cited by
Guidelines for minimal information on cellular senescence experimentation in vivo
Ogrodnik, M., Carlos Acosta, J., Adams, P. D., d’Adda di Fagagna, F., Baker, D. J., Bishop, C. L., Chandra, T., Collado, M., Gil, J., Gorgoulis, V., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.059 · Cited by 376
Cardiac cell senescence: molecular mechanisms, key proteins and therapeutic targets
Luan, Y., Zhu, X., Jiao, Y., Liu, H., Huang, Z., Pei, J., Xu, Y., Yang, Y., & Ren, K. (2024) · Cell Death Discovery · doi:10.1038/s41420-023-01792-5 · Cited by 122
Regulation of substrate utilization and adiposity by Agrp neurons
Cavalcanti-de-Albuquerque, J. P., Bober, J., Zimmer, M. R., & Dietrich, M. O. (2019) · Nature Communications · doi:10.1038/s41467-018-08239-x · Cited by 100
Wang, Y., Chu, F., Lin, J., Li, Y., Johnson, N. L., Zhang, J., Gai, C., Su, Z., Cheng, H.-J., Wang, L., et al. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114399 · Cited by 95
CDKN1A/p21 in Breast Cancer: Part of the Problem, or Part of the Solution?
Manousakis, E., Miralles, C. M., Esquerda, M. G., & Wright, R. H. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417488 · Cited by 83
Metadata
- Authors
- Mansilla, S. F., De La Vega, M. B., Calzetta, N. L., Siri, S. O., & Gottifredi, V.
- Affiliations
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- Cell Cycle and Genomic Stability Laboratory, Fundación Instituto Leloir, IIBBA-CONICET, Av. Patricias Argentinas 435, Buenos Aires 1405, Argentina
- Corresponding author
- Gottifredi, Vanesa
- Venue
- Genes
- Publisher
- MDPI AG
- Published
- 2020-05-28
- Volume
- 11
- Issue
- 6
- Pages
- 593
- ISSN
- 2073-4425 (ISSN-L)
- PMC
- PMC7349641
- OpenAlex
- W3030260166
- Semantic Scholar
- 1a60fb98d0bf4fd8673c22ae4a9ffbd4266624fd
- Cited by
- 114
- References
- 125
- Citations by year
- 2026: 10 · 2025: 18 · 2024: 22 · 2023: 22 · 2022: 20 · 2021: 16 · 2020: 5
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Genes (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- CONICET Digital (CONICET) (submittedVersion, cc-by-nc-sa)
- Funders
- Agencia Nacional de Promoción Científica y Tecnológica (PICT 2016- 1239, PICT 2017-0612)
- Instituto Nacional del Cáncer (No grant number)
- Ben Barres spotlight award from eLIFE (No grant number)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- p21, DNA replication, cyclin-dependent kinases, PCNA, S phase, origin firing, genome stability, p53, cell cycle arrest, chromatin binding, cancer therapy
- MeSH terms
- DNA Replication, Humans, S Phase, Proliferating Cell Nuclear Antigen, Cyclin-Dependent Kinases, Protein Kinase Inhibitors, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.